TrialInternational journal of chronic obstructive pulmonary disease2016

A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD.

Gregory Feldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.